SEC Form 4 · accession 0001127602-17-025502
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas C Zielinski
Officer — EVP & General Counsel
Period of report
Aug 10, 2017
Accepted (ET)
Aug 11, 2017 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2017 | M | 9,127 | $108.35 | A | 26,571 | D | |
| Common Stock | Aug 10, 2017 | S | 3,100 | $189.85 | D | 23,471 | D | |
| Common StockF1 | Aug 10, 2017 | S | 5,027 | $191.82 | D | 18,444 | D | |
| Common StockF2 | Aug 10, 2017 | S | 1,000 | $192.76 | D | 17,444 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3 | $108.35 | Aug 10, 2017 | M | 9,127 | D | — | Jun 2, 2021 | Common Stock | 9,127 | 7,064 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $191.50 to $192.48. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $192.53 to $192.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The option represents a right to purchase a total of 21,191 shares, and is exercisable in six semi-annual installments with one installment of 3,531 shares and five installments of 3,532 shares each beginning on 12/2/14, which is the six-month anniversary of the date on which the option was granted.